Abstract
Despite rapid progress in our knowledge of hepatitis C virology and pathogenesis, little is known about the current and future burden of this infection throughout the world. Prevalence and population-based studies have suggested that complications of the liver disease associated with chronic hepatitis C infection may potentially require substantial health care resources and generate very high costs for medical systems in the United States, Europe and worldwide. Careful understanding and assessment of hepatitis C health and economic burdens are likely to guide better programs for the management of infected individuals and the prevention of complications.
Original language | English (US) |
---|---|
Pages (from-to) | 1219-1225 |
Number of pages | 7 |
Journal | Microbes and Infection |
Volume | 4 |
Issue number | 12 |
DOIs | |
State | Published - Oct 2002 |
Keywords
- Epidemiology
- Health care costs
- Hepatitis C
- Morbidity
- Mortality
ASJC Scopus subject areas
- Microbiology
- Immunology
- Infectious Diseases